Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Miliaria rubra and thrombocytosis in pseudohypoaldosteronism: case report.

Onal H, Adal E, Ersen A, Onal Z, Keskindemirci G.

Platelets. 2012;23(8):645-7. doi: 10.3109/09537104.2011.641624. Epub 2011 Dec 13.

PMID:
22150373
[PubMed - indexed for MEDLINE]
2.

[Pustular miliaria rubra and systemic type 1b pseudohypoaldosteronism in a newborn].

Argoubi H, Fitchner C, Richard O, Lavocat MP, Cambazard F, Stéphan JL.

Ann Dermatol Venereol. 2007 Mar;134(3 Pt 1):253-6. French.

PMID:
17389851
[PubMed - indexed for MEDLINE]
3.

Pustular miliaria rubra: a specific cutaneous finding of type I pseudohypoaldosteronism.

Urbatsch A, Paller AS.

Pediatr Dermatol. 2002 Jul-Aug;19(4):317-9.

PMID:
12220275
[PubMed - indexed for MEDLINE]
4.

Clinico-pathological analysis of the cutaneous lesions of a patient with type I pseudohypoaldosteronism.

Martín JM, Calduch L, Monteagudo C, Alonso V, García L, Jordá E.

J Eur Acad Dermatol Venereol. 2005 May;19(3):377-9.

PMID:
15857472
[PubMed - indexed for MEDLINE]
5.

[Sweat glands in pseudohypoaldosteronism].

Aberer E, Gebhart W, Mainitz M, Pollak A, Reichel G, Scheibenreiter S.

Hautarzt. 1987 Aug;38(8):484-7. German.

PMID:
3654220
[PubMed - indexed for MEDLINE]
6.

Newborn with pseudohypoaldosteronism and miliaria rubra.

Akcakus M, Koklu E, Poyrazoglu H, Kurtoglu S.

Int J Dermatol. 2006 Dec;45(12):1432-4. No abstract available.

PMID:
17184247
[PubMed - indexed for MEDLINE]
7.

A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.

Lee SE, Jung YH, Han KH, Lee HK, Kang HG, Ha IS, Choi Y, Cheong HI.

Korean J Pediatr. 2011 Feb;54(2):90-3. doi: 10.3345/kjp.2011.54.2.90. Epub 2011 Feb 28.

PMID:
21503203
[PubMed]
Free PMC Article
8.

[Mineralocorticoid resistance: pseudohypoaldosteronism type 1].

Fernandes-Rosa FL, Antonini SR.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):373-81. Review. Portuguese.

PMID:
17546235
[PubMed - indexed for MEDLINE]
Free Article
9.

A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.

Tajima T, Kitagawa H, Yokoya S, Tachibana K, Adachi M, Nakae J, Suwa S, Katoh S, Fujieda K.

J Clin Endocrinol Metab. 2000 Dec;85(12):4690-4.

PMID:
11134129
[PubMed - indexed for MEDLINE]
10.

Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.

Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP.

Nat Genet. 1998 Jul;19(3):279-81.

PMID:
9662404
[PubMed - indexed for MEDLINE]
11.

Autosomal dominant pseudohypoaldosteronism type 1 in an infant with salt wasting crisis associated with urinary tract infection and obstructive uropathy.

Bowden SA, Cozzi C, Hickey SE, Thrush DL, Astbury C, Nuthakki S.

Case Rep Endocrinol. 2013;2013:524647. doi: 10.1155/2013/524647. Epub 2013 Dec 19.

PMID:
24455331
[PubMed]
Free PMC Article
12.

[Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].

Arai K, Shibasaki T.

Nihon Rinsho. 2002 Feb;60(2):361-6. Review. Japanese.

PMID:
11857927
[PubMed - indexed for MEDLINE]
13.

Pseudohypoaldosteronism.

Riepe FG.

Endocr Dev. 2013;24:86-95. doi: 10.1159/000342508. Epub 2013 Feb 1. Review.

PMID:
23392097
[PubMed - indexed for MEDLINE]
14.

Autosomal dominant pseudohypoaldosteronism type 1 with a novel splice site mutation in MR gene.

Kanda K, Nozu K, Yokoyama N, Morioka I, Miwa A, Hashimura Y, Kaito H, Iijima K, Matsuo M.

BMC Nephrol. 2009 Nov 14;10:37. doi: 10.1186/1471-2369-10-37.

PMID:
19912655
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pseudohypoaldosteronisms, report on a 10-patient series.

Belot A, Ranchin B, Fichtner C, Pujo L, Rossier BC, Liutkus A, Morlat C, Nicolino M, Zennaro MC, Cochat P.

Nephrol Dial Transplant. 2008 May;23(5):1636-41. doi: 10.1093/ndt/gfm862.

PMID:
18424465
[PubMed - indexed for MEDLINE]
Free Article
16.

A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.

Uchida N, Shiohara M, Miyagawa S, Yokota I, Mori T.

J Pediatr Endocrinol Metab. 2009 Jan;22(1):91-5.

PMID:
19344080
[PubMed - indexed for MEDLINE]
17.

Clinical and molecular features of type 1 pseudohypoaldosteronism.

Riepe FG.

Horm Res. 2009;72(1):1-9. doi: 10.1159/000224334. Epub 2009 Jun 30. Review.

PMID:
19571553
[PubMed - indexed for MEDLINE]
18.

Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.

Pujo L, Fagart J, Gary F, Papadimitriou DT, Claës A, Jeunemaître X, Zennaro MC.

Hum Mutat. 2007 Jan;28(1):33-40.

PMID:
16972228
[PubMed - indexed for MEDLINE]
19.

Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism.

Bistritzer T, Kerem E, Berkovitch M, Rapoport MJ, Evans S, Aladjem M.

Clin Endocrinol (Oxf). 2002 May;56(5):575-80.

PMID:
12030906
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk